Business Context and Reporting Period
This Form 8-K is a current report filed by cbdMD, Inc. on February 28, 2022. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD (Common Stock) and YCBDpA (8.0% Series A Cumulative Convertible Preferred Stock). The filing reports on the issuance of unregistered equity securities pursuant to a prior merger agreement.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue totals, profit margins, cash flow, debt levels, or liquidity ratios for the reporting period. The only specific financial figure disclosed is the net revenue for a specific quarter used to calculate an earnout payment:
- Net Revenue (Q4 2021): $9,321,822 (Used to determine earnout share issuance).
Material Changes and Events
The primary event reported is the issuance of 444,243 shares of common stock on February 28, 2022. This issuance was triggered by the satisfaction of net revenue criteria for the quarter ended December 31, 2021, under the "Earnout Rights" established in the 2018 Merger Agreement with Cure Based Development, LLC. The recipients of these shares were members of CBD Holding, LLC, including affiliates of executive officers Martin A. Sumichrast and R. Scott Coffman.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction. The issuance was made to accredited investors and was exempt from registration under Section 4(a)(2) of the Securities Act of 1933. The filing notes that the measurement periods for the earnout were amended in March 2021 to a quarterly basis.
Key Facts for Investor Verification
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Confirm the remaining earnout milestones and potential future share issuances under the amended Merger Agreement.
- Review the full Q4 2021 financial results in the company's 10-Q or 10-K to contextualize the $9.32 million revenue figure.
- Check for any subsequent filings regarding the status of the remaining earnout periods.